All staff should be aware that the Stanford Institutional Review Board (IRB) has moved and officially changed their address.  The new location is a few blocks away from the old location, still on El Camino Real (at the corner of Park Blvd / Serra St).  This location is actually closer to the Cancer Center than the old location at El Camino Real and Page Mill.

All studies should update their materials, in particular the Form FDA 1572 (if used), with the new address.

Name of IRB:      Administrative Panels on Human Subjects in Medical Research (“Stanford IRB”);  Research Compliance Office; Stanford University

Address 1:           1705 El Camino Real

Address 2:           <LEAVE THIS LINE BLANK>

City:  Palo Alto          State:  CA                Country:  USA            Zip: 94306

Please note that it is important to use the full, formal name of the IRB, as above.  FDA has previously issued findings regarding the use of only “Stanford IRB.”  While the name provided is long, it is correct and fits within the provided field on the Form FDA 1572.

All drug studies conducted under an IND should update their Form FDA 1572 accordingly at the next revision.  If made aware of the change, some sponsors may ask for this immediately.

All Investigator-initiated Studies (IISs/IITs) for drugs should update their Form FDA 1572 at the next IND submission, and not later than the next IND annual report.

At this time, be sure to check that the list of physician sub-investigators is 100% in agreement between the Form FDA 1572 with eProtocol.